Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Comparison Of Deep Sequencing and Allele-Specific Oligonucleotide PCR Methods For MRD Quantitation In Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma: CALGB 10403 and CALGB 59909 (Alliance)

Greg Malnassy, MS, Susan Geyer, PhD, Noreen Fulton, B.S., Greg Koval, B.S., Donna Niedzwiecki, PhD, Victoria Carlton, PhD, Li Weng, PhD, Lawrence D. Kaplan, MD, Guido Marcucci, MD, Lloyd E Damon, MD, Richard A. Larson, MD, Richard M. Stone, MD, Bruce D. Cheson, M.D., Malek Faham, MD, PhD, Wendy Stock, M.D.

Blood (2013) 122 (21): 2547.

https://doi.org/10.1182/blood.V122.21.2547.2547

Published: 2013

Journal Articles

The Impact of Lymphocyte Subset Recovery At 3 Months on Progression-Free Survival After Myeloablative Allogeneic Stem Cell Transplantation,

Junya Kanda, MD, David A. Rizzieri, MD, Gwynn D. Long, MD, Cristina Gasparetto, MD, John P. Chute, MD, Keith M. Sullivan, MD, Ashley Morris, PharmD, Jacalyn McPherson, J. Andrew Livingston, MD, Gloria Broadwater, MS, Donna Niedzwiecki, PhD, Nelson J. Chao, MD, Mitchell E. Horwitz, MD

Blood (2011) 118 (21): 4065.

https://doi.org/10.1182/blood.V118.21.4065.4065

Published: 2011

Journal Articles

Adult Dual Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation (1350cGy) and Fludarabine Conditioning

Junya Kanda, MD, David A. Rizzieri, MD, Cristina Gasparetto, MD, Gwynn D. Long, MD, John P. Chute, MD, Keith M. Sullivan, MD, Ashley Morris, PharmD, Clayton A. Smith, MD, FRCPC, Donna E. Hogge, MD, PhD, Janet Nitta, Kevin Song, MD, Donna Niedzwiecki, PhD, Nelson J. Chao, MD, Mitchell E. Horwitz, MD

Blood (2010) 116 (21): 3523.

https://doi.org/10.1182/blood.V116.21.3523.3523

Published: 2010

Journal Articles

A Comprehensive Comparison Immune Recovery In Adult Patients Following Allogeneic Umbilical Cord Blood, Matched Sibling and Matched Unrelated Donor Stem Cell Transplantation

Lun-Wei Chiou, MD, Junya Kanda, MD, Paul Szabolcs, MD, Gregory E. Sempowski, PhD, Jeffrey Hale, Donna Niedzwiecki, PhD, Gloria Broadwater, MS, Nelson J. Chao, MD, Mitchell E. Horwitz, MD

Blood (2010) 116 (21): 2313.

https://doi.org/10.1182/blood.V116.21.2313.2313

Published: 2010

Journal Articles

Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines

Michael A. Morse, Amy C. Hobeika, Takuya Osada, Delila Serra, Donna Niedzwiecki, H. Kim Lyerly, Timothy M. Clay

Blood (2008) 112 (3): 610–618.

https://doi.org/10.1182/blood-2008-01-135319

Published: 2008

Journal Articles

Immuno-Chemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909.

Lloyd E. Damon, MD, Jeff Johnson, Donna Niedzwiecki, Bruce D. Cheson, MD, David Duane Hurd, MD, Nancy L. Bartlett, MD, John C. Byrd, Michael Kelly, Charles Linker, MD, George P. Canellos, MD

Blood (2006) 108 (11): 2737.

https://doi.org/10.1182/blood.V108.11.2737.2737

Published: 2006

Journal Articles

Multivariate Analysis of Patient and Graft Specific Factors among 330 Recipients of Unrelated Cord Blood Transplant (UCBT) To Predict Risk of Death from Opportunistic Infections in the First 6 Months after UCBT.

Paul Szabolcs, MD, Bercedis L. Peterson, PhD, Donna Niedzwiecki, PhD, Nelson Chao, MD, Joanne Kurtzberg, MD

Blood (2006) 108 (11): 2860.

https://doi.org/10.1182/blood.V108.11.2860.2860

Published: 2006

Journal Articles

Outcome and Immune Reconstitution Following T Cell Depleted Nonmyeloablative Allogeneic Transplantation Using Matched Donors.

David A. Rizzieri, MD, Liang Piu Koh, MD, Gwynn D. Long, MD, Cristina Gasparetto, MD, Jerald Z. Gong, MD, Anand S. Lagoo, MD, Donna Niedzwiecki, PhD, Keith M. Sullivan, MD, John Chute, MD, Mitchell Horwitz, MD, Morris Ashley, PharmD, Nelson J. Chao, MD

Blood (2005) 106 (11): 2036.

https://doi.org/10.1182/blood.V106.11.2036.2036

Published: 2005

Journal Articles

Partially HLA Matched, Non-Myeloablative Allogeneic Transplantation.

David A. Rizzieri, MD, Liang Piu Koh, MD, Gwynn D. Long, MD, Cristina Gasparetto, MD, Keith M. Sullivan, MD, Mitchell Horwitz, MD, John Chute, MD, Jerald Z. Gong, MD, Anand S. Lagoo, MD, Donna Niedzwiecki, PhD, Cong Xiao Lu, MD, Dawn Marshall, BS, Jeanette M. Dowell, MS, Nelson J. Chao, MD

Blood (2005) 106 (11): 2896.

https://doi.org/10.1182/blood.V106.11.2896.2896

Published: 2005

Journal Articles

Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34

Robert W. Storms, Patrick D. Green, Kristine M. Safford, Donna Niedzwiecki, Christopher R. Cogle, O. Michael Colvin, Nelson J. Chao, Henry E. Rice, Clayton A. Smith

Blood (2005) 106 (1): 95–102.

https://doi.org/10.1182/blood-2004-09-3652

Published: 2005

Journal Articles

Dendritic and T Cell Subsets Correlate with the Development and Site of Acute GVHD Following Unrelated Cord Blood Transplantation. A Multivariate Analysis of Host, Graft, and Day+50 Immune Profile.

Paul Szabolcs, MD, Kyung-Duk Park, MD, Luciana Marti, Young-Ah Lee, Melissa Reese, Linda Sanders, Donna Niedzwiecki, PhD, Joanne Kurtzberg, MD

Blood (2004) 104 (11): 981.

https://doi.org/10.1182/blood.V104.11.981.981

Published: 2004

Journal Articles

Intense Immunochemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909. A Preliminary Report.

Lloyd Damon, Donna Niedzwiecki, Jeff Johnson, Bruce Cheson, David Hurd, Nancy Barlett, Michael Kelly, Charles Linker, George Canellos

Blood (2004) 104 (11): 895.

https://doi.org/10.1182/blood.V104.11.895.895

Published: 2004

Journal Articles

Dose Dense, High Intensity Induction Therapy Followed by Early High Dose Chemotherapy (HDT) and Autologous Hematopoietic Stem Cell Transplantation(AHSCT) for Mantle Cell Lymphoma (MCL).

Liang-Piu Koh, MRCP, Jon P. Gockerman, MD, Joseph O. Moore, MD, Carlos DeCastro, MD, Gwynn D. Long, MD, Cristina Gasparetto, MD, Donna Niedzwiecki, PhD, Jon Edwards, MD, Leonard Prosnitz, MD, Mitchell Horwitz, MD, Jon Chute, MD, Ashley Morris, Pharm D, Martha Lassiter, Jennifer Loftis, Patty Davis, Nelson J. Chao, MD, David A. Rizzieri, MD

Blood (2004) 104 (11): 913.

https://doi.org/10.1182/blood.V104.11.913.913

Published: 2004

Journal Articles

CALGB 59901: Results of a Phase II Study of 506U78 in CTCL and PTCL.

Myron S. Czuczman, MD, Pierluigi Porcu, MD, Jeff Johnson, Donna Niedzwiecki, George P. Canellos, MD, Bruce D. Cheson, MD

Blood (2004) 104 (11): 2486.

https://doi.org/10.1182/blood.V104.11.2486.2486

Published: 2004

Journal Articles

Sequential Topoisomerase I (Topo I) and Topoisomerase II (Topo II) Inhibitors in Relapsed/Refractory Aggressive NHL: Results of CALGN 59906, a Phase II Study of Doxorubicin and Topotecan.

Sonali M. Smith, MD, Jeffrey L. Johnson, MS, Donna Niedzwiecki, PhD, J. Paul Eder, MD, George P. Canellos, MD, Bruce D. Cheson, MD, Nancy L. Bartlett, MD

Blood (2004) 104 (11): 2500.

https://doi.org/10.1182/blood.V104.11.2500.2500

Published: 2004

NARROW

Comparison Of Deep Sequencing and Allele-Specific Oligonucleotide PCR Methods For MRD Quantitation In Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma: CALGB 10403 and CALGB 59909 (Alliance)

The Impact of Lymphocyte Subset Recovery At 3 Months on Progression-Free Survival After Myeloablative Allogeneic Stem Cell Transplantation,

Adult Dual Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation (1350cGy) and Fludarabine Conditioning

A Comprehensive Comparison Immune Recovery In Adult Patients Following Allogeneic Umbilical Cord Blood, Matched Sibling and Matched Unrelated Donor Stem Cell Transplantation

Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines

Immuno-Chemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909.

Multivariate Analysis of Patient and Graft Specific Factors among 330 Recipients of Unrelated Cord Blood Transplant (UCBT) To Predict Risk of Death from Opportunistic Infections in the First 6 Months after UCBT.

Outcome and Immune Reconstitution Following T Cell Depleted Nonmyeloablative Allogeneic Transplantation Using Matched Donors.

Partially HLA Matched, Non-Myeloablative Allogeneic Transplantation.

Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34

Dendritic and T Cell Subsets Correlate with the Development and Site of Acute GVHD Following Unrelated Cord Blood Transplantation. A Multivariate Analysis of Host, Graft, and Day+50 Immune Profile.

Intense Immunochemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909. A Preliminary Report.

Dose Dense, High Intensity Induction Therapy Followed by Early High Dose Chemotherapy (HDT) and Autologous Hematopoietic Stem Cell Transplantation(AHSCT) for Mantle Cell Lymphoma (MCL).

CALGB 59901: Results of a Phase II Study of 506U78 in CTCL and PTCL.

Sequential Topoisomerase I (Topo I) and Topoisomerase II (Topo II) Inhibitors in Relapsed/Refractory Aggressive NHL: Results of CALGN 59906, a Phase II Study of Doxorubicin and Topotecan.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only